A randomized controlled trial of the effectiveness of planning strategies in the adherence to medication for coronary artery disease

J Adv Nurs. 2014 Jul;70(7):1616-28. doi: 10.1111/jan.12323. Epub 2013 Dec 3.

Abstract

Aim: To examine the effect of action and coping planning strategies in the adherence to medication among outpatients with coronary artery disease.

Background: Action and coping planning strategies are based on implementation intention, which requires self-regulation by the individual, to prioritize intentionally planned responses over learned or habitual ones, from daily routines to stressful situations.

Design: Randomized controlled trial.

Methods: Participants (n = 115) were randomized into intervention (use of action and coping planning strategies, n = 59) or control (usual care, n = 56) groups. The study was conducted between June 2010-May 2011 in two in-person visits: baseline and 2-month follow-up. Participants in the intervention group received telephone reinforcement between baseline and 2-month follow-up. Adherence to medication for cardioprotection and symptoms relief was evaluated by proportion of adherence, global measure of adherence evaluation and Morisky Self-Reported Measure of Medication Adherence Scale at both baseline and 2-month follow-up.

Findings: When using the measure of global measure of adherence, participants in the intervention group reported adherence to therapy more often than controls (odds ratio = 5.3), but no statistically significant change was observed in the other two outcome measures.

Conclusion: This study has shown that individuals who use action and coping planning report higher adherence to drug treatment, when measured by the global adherence evaluation. Further studies with longer follow-ups are needed to assess if the effect of planning strategies has long-term duration.

Keywords: adherence; coronary disease; intervention studies; nurses/midwives/nursing; planning techniques; randomized controlled trials.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Coronary Artery Disease / drug therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Patient Care Planning*
  • Patient Compliance*